762 related articles for article (PubMed ID: 26700233)
1. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
Ramalingam P; Ko YT
Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
6. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
7. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
9. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
10. [pH-sensitive micelles loaded paclitaxel using carboxymethyl chitosan-palmitic acid mediated by cRGD].
Li JZ; Yuan ZQ; Yan M; Li MW; Zhang XN
Yao Xue Xue Bao; 2016 Apr; 51(4):642-9. PubMed ID: 29860751
[TBL] [Abstract][Full Text] [Related]
11. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
Neves AR; Lúcio M; Martins S; Lima JL; Reis S
Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
[TBL] [Abstract][Full Text] [Related]
12. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
13. Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery.
Facchi SP; Scariot DB; Bueno PV; Souza PR; Figueiredo LC; Follmann HD; Nunes CS; Monteiro JP; Bonafé EG; Nakamura CV; Muniz EC; Martins AF
Int J Biol Macromol; 2016 Jun; 87():237-45. PubMed ID: 26930578
[TBL] [Abstract][Full Text] [Related]
14. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
16. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
17. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
18. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.
Farhadian A; Dounighi NM; Avadi M
Hum Vaccin Immunother; 2015; 11(12):2811-8. PubMed ID: 26158754
[TBL] [Abstract][Full Text] [Related]
19. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol cross-linked chitosan loaded with phospholipid for controlled release and antioxidant activity.
Jeong H; Samdani KJ; Yoo DH; Lee DW; Kim NH; Yoo IS; Lee JH
Int J Biol Macromol; 2016 Dec; 93(Pt A):757-766. PubMed ID: 27614196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]